Evolving clinical cancer radiotherapy: Concerns regarding normal tissue protection and quality assurance

Won Hoon Choi, Jaeho Cho

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Radiotherapy, which is one of three major cancer treatment methods in modern medicine, has continued to develop for a long period, more than a century. The development of radiotherapy means allowing the administration of higher doses to tumors to improve tumor control rates while minimizing the radiation doses absorbed by surrounding normal tissues through which radiation passes for administration to tumors, thereby reducing or removing the incidence of side effects. Such development of radiotherapy was accomplished by the development of clinical radiation oncology, the development of computers and machine engineering, the introduction of cutting-edge imaging technology, a deepened understanding of biological studies on the effects of radiation on human bodies, and the development of quality assurance (QA) programs in medical physics. The development of radiotherapy over the last two decades has been quite dazzling. Due to continuous improvements in cancer treatment, the average five-year survival rate of cancer patients has been close to 70%. The increases in cancer patients' complete cure rates and survival periods are making patients' quality of life during or after treatment a vitally important issue. Radiotherapy is implemented in approximately 1/3 to 2/3s of all cancer patients; and has improved the quality of life of cancer patients in the present age. Over the last century, as a noninvasive treatment, radiotherapy has unceasingly enhanced complete tumor cure rates and the side effects of radiotherapy have been gradually decreasing, resulting in a tremendous improvement in the quality of life of cancer patients.

Original languageEnglish
Pages (from-to)S75-S87
JournalJournal of Korean medical science
Volume31
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Radiotherapy
Neoplasms
Quality of Life
Survival Rate
Radiation
Modern 1601-history
Radiation Oncology
Medical Oncology
Radiation Effects
Physics
Human Development
Therapeutics
Human Body
Technology
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{8a87532c3bac472f83d27bbb7ce2d547,
title = "Evolving clinical cancer radiotherapy: Concerns regarding normal tissue protection and quality assurance",
abstract = "Radiotherapy, which is one of three major cancer treatment methods in modern medicine, has continued to develop for a long period, more than a century. The development of radiotherapy means allowing the administration of higher doses to tumors to improve tumor control rates while minimizing the radiation doses absorbed by surrounding normal tissues through which radiation passes for administration to tumors, thereby reducing or removing the incidence of side effects. Such development of radiotherapy was accomplished by the development of clinical radiation oncology, the development of computers and machine engineering, the introduction of cutting-edge imaging technology, a deepened understanding of biological studies on the effects of radiation on human bodies, and the development of quality assurance (QA) programs in medical physics. The development of radiotherapy over the last two decades has been quite dazzling. Due to continuous improvements in cancer treatment, the average five-year survival rate of cancer patients has been close to 70{\%}. The increases in cancer patients' complete cure rates and survival periods are making patients' quality of life during or after treatment a vitally important issue. Radiotherapy is implemented in approximately 1/3 to 2/3s of all cancer patients; and has improved the quality of life of cancer patients in the present age. Over the last century, as a noninvasive treatment, radiotherapy has unceasingly enhanced complete tumor cure rates and the side effects of radiotherapy have been gradually decreasing, resulting in a tremendous improvement in the quality of life of cancer patients.",
author = "Choi, {Won Hoon} and Jaeho Cho",
year = "2016",
month = "1",
day = "1",
doi = "10.3346/jkms.2016.31.S1.S75",
language = "English",
volume = "31",
pages = "S75--S87",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",

}

Evolving clinical cancer radiotherapy : Concerns regarding normal tissue protection and quality assurance. / Choi, Won Hoon; Cho, Jaeho.

In: Journal of Korean medical science, Vol. 31, 01.01.2016, p. S75-S87.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evolving clinical cancer radiotherapy

T2 - Concerns regarding normal tissue protection and quality assurance

AU - Choi, Won Hoon

AU - Cho, Jaeho

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Radiotherapy, which is one of three major cancer treatment methods in modern medicine, has continued to develop for a long period, more than a century. The development of radiotherapy means allowing the administration of higher doses to tumors to improve tumor control rates while minimizing the radiation doses absorbed by surrounding normal tissues through which radiation passes for administration to tumors, thereby reducing or removing the incidence of side effects. Such development of radiotherapy was accomplished by the development of clinical radiation oncology, the development of computers and machine engineering, the introduction of cutting-edge imaging technology, a deepened understanding of biological studies on the effects of radiation on human bodies, and the development of quality assurance (QA) programs in medical physics. The development of radiotherapy over the last two decades has been quite dazzling. Due to continuous improvements in cancer treatment, the average five-year survival rate of cancer patients has been close to 70%. The increases in cancer patients' complete cure rates and survival periods are making patients' quality of life during or after treatment a vitally important issue. Radiotherapy is implemented in approximately 1/3 to 2/3s of all cancer patients; and has improved the quality of life of cancer patients in the present age. Over the last century, as a noninvasive treatment, radiotherapy has unceasingly enhanced complete tumor cure rates and the side effects of radiotherapy have been gradually decreasing, resulting in a tremendous improvement in the quality of life of cancer patients.

AB - Radiotherapy, which is one of three major cancer treatment methods in modern medicine, has continued to develop for a long period, more than a century. The development of radiotherapy means allowing the administration of higher doses to tumors to improve tumor control rates while minimizing the radiation doses absorbed by surrounding normal tissues through which radiation passes for administration to tumors, thereby reducing or removing the incidence of side effects. Such development of radiotherapy was accomplished by the development of clinical radiation oncology, the development of computers and machine engineering, the introduction of cutting-edge imaging technology, a deepened understanding of biological studies on the effects of radiation on human bodies, and the development of quality assurance (QA) programs in medical physics. The development of radiotherapy over the last two decades has been quite dazzling. Due to continuous improvements in cancer treatment, the average five-year survival rate of cancer patients has been close to 70%. The increases in cancer patients' complete cure rates and survival periods are making patients' quality of life during or after treatment a vitally important issue. Radiotherapy is implemented in approximately 1/3 to 2/3s of all cancer patients; and has improved the quality of life of cancer patients in the present age. Over the last century, as a noninvasive treatment, radiotherapy has unceasingly enhanced complete tumor cure rates and the side effects of radiotherapy have been gradually decreasing, resulting in a tremendous improvement in the quality of life of cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=84958793713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958793713&partnerID=8YFLogxK

U2 - 10.3346/jkms.2016.31.S1.S75

DO - 10.3346/jkms.2016.31.S1.S75

M3 - Article

C2 - 26908993

AN - SCOPUS:84958793713

VL - 31

SP - S75-S87

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

ER -